Skip to main content
. 2015 Jan 15;191(2):208–218. doi: 10.1164/rccm.201409-1742OC

Figure 3.

Figure 3.

Survival curve for serum endostatin (ES) in pulmonary arterial hypertension (PAH). (A) Kaplan-Meier survival analysis of derivation cohort dichotomized by serum ES levels; n = 82, P = 0.001. (B) Kaplan-Meier survival analysis of a validation idiopathic PAH cohort; n = 50, P = 0.02.